Selected research
Industry Research
AI Pathology Analysis System Industry Research Report 2026
Market perspective
The global AI Pathology Analysis System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI Pathology Analysis System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI Pathology Analysis System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI Pathology Analysis System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI Pathology Analysis System include Visiopharm, PathAI, Aiforia, Indica Labs, aetherAI, Proscia, Mindpeak, Techcyte and Qritive, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI Pathology Analysis System market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI Pathology Analysis System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI Pathology Analysis System Market by Company
Visiopharm
PathAI
Aiforia
Indica Labs
aetherAI
Proscia
Mindpeak
Techcyte
Qritive
Deepathology
Franklin.ai
Roche Diagnostics
Flagship
Dedalus Group
Ibex Medical Analytics
AI Pathology Analysis System Segment by Type
On-premises
Cloud-based
AI Pathology Analysis System Segment by Application
Hospital
Clinic
Others
AI Pathology Analysis System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Pathology Analysis System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI Pathology Analysis System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Pathology Analysis System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI Pathology Analysis System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-premises
- Cloud-based
Applications
- Hospital
- Clinic
- Others
Companies covered
- Visiopharm
- PathAI
- Aiforia
- Indica Labs
- aetherAI
- Proscia
- Mindpeak
- Techcyte
- Qritive
- Deepathology
- Franklin.ai
- Roche Diagnostics
- Flagship
- Dedalus Group
- Ibex Medical Analytics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI Pathology Analysis System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-premises
- 2.2.3 Cloud-based
- 2.3 AI Pathology Analysis System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Clinic
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 AI Pathology Analysis System Breakdown Data by Type
- 3.1 Global AI Pathology Analysis System Historic Market Size by Type (2021-2026)
- 3.2 Global AI Pathology Analysis System Forecasted Market Size by Type (2027-2032)
4 AI Pathology Analysis System Breakdown Data by Application
- 4.1 Global AI Pathology Analysis System Historic Market Size by Application (2021-2026)
- 4.2 Global AI Pathology Analysis System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI Pathology Analysis System Market Perspective (2021-2032)
- 5.2 Global AI Pathology Analysis System Growth Trends by Region
- 5.2.1 Global AI Pathology Analysis System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI Pathology Analysis System Historic Market Size by Region (2021-2026)
- 5.2.3 AI Pathology Analysis System Forecasted Market Size by Region (2027-2032)
- 5.3 AI Pathology Analysis System Market Dynamics
- 5.3.1 AI Pathology Analysis System Industry Trends
- 5.3.2 AI Pathology Analysis System Market Drivers
- 5.3.3 AI Pathology Analysis System Market Challenges
- 5.3.4 AI Pathology Analysis System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI Pathology Analysis System Players by Revenue
- 6.1.1 Global Top AI Pathology Analysis System Players by Revenue (2021-2026)
- 6.1.2 Global AI Pathology Analysis System Revenue Market Share by Players (2021-2026)
- 6.2 Global AI Pathology Analysis System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI Pathology Analysis System Head Office and Area Served
- 6.4 Global AI Pathology Analysis System Players, Product Type & Application
- 6.5 Global AI Pathology Analysis System Manufacturers Established Date
- 6.6 Global AI Pathology Analysis System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI Pathology Analysis System Market Size (2021-2032)
- 7.2 North America AI Pathology Analysis System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI Pathology Analysis System Market Size by Country (2021-2026)
- 7.4 North America AI Pathology Analysis System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI Pathology Analysis System Market Size (2021-2032)
- 8.2 Europe AI Pathology Analysis System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI Pathology Analysis System Market Size by Country (2021-2026)
- 8.4 Europe AI Pathology Analysis System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI Pathology Analysis System Market Size (2021-2032)
- 9.2 Asia-Pacific AI Pathology Analysis System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI Pathology Analysis System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI Pathology Analysis System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI Pathology Analysis System Market Size (2021-2032)
- 10.2 South America AI Pathology Analysis System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI Pathology Analysis System Market Size by Country (2021-2026)
- 10.4 South America AI Pathology Analysis System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI Pathology Analysis System Market Size (2021-2032)
- 11.2 Middle East & Africa AI Pathology Analysis System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI Pathology Analysis System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI Pathology Analysis System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Visiopharm
- 12.1.1 Visiopharm Company Information
- 12.1.2 Visiopharm Business Overview
- 12.1.3 Visiopharm Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.1.4 Visiopharm AI Pathology Analysis System Product Portfolio
- 12.1.5 Visiopharm Recent Developments
- 12.2 PathAI
- 12.2.1 PathAI Company Information
- 12.2.2 PathAI Business Overview
- 12.2.3 PathAI Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.2.4 PathAI AI Pathology Analysis System Product Portfolio
- 12.2.5 PathAI Recent Developments
- 12.3 Aiforia
- 12.3.1 Aiforia Company Information
- 12.3.2 Aiforia Business Overview
- 12.3.3 Aiforia Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.3.4 Aiforia AI Pathology Analysis System Product Portfolio
- 12.3.5 Aiforia Recent Developments
- 12.4 Indica Labs
- 12.4.1 Indica Labs Company Information
- 12.4.2 Indica Labs Business Overview
- 12.4.3 Indica Labs Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.4.4 Indica Labs AI Pathology Analysis System Product Portfolio
- 12.4.5 Indica Labs Recent Developments
- 12.5 aetherAI
- 12.5.1 aetherAI Company Information
- 12.5.2 aetherAI Business Overview
- 12.5.3 aetherAI Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.5.4 aetherAI AI Pathology Analysis System Product Portfolio
- 12.5.5 aetherAI Recent Developments
- 12.6 Proscia
- 12.6.1 Proscia Company Information
- 12.6.2 Proscia Business Overview
- 12.6.3 Proscia Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.6.4 Proscia AI Pathology Analysis System Product Portfolio
- 12.6.5 Proscia Recent Developments
- 12.7 Mindpeak
- 12.7.1 Mindpeak Company Information
- 12.7.2 Mindpeak Business Overview
- 12.7.3 Mindpeak Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.7.4 Mindpeak AI Pathology Analysis System Product Portfolio
- 12.7.5 Mindpeak Recent Developments
- 12.8 Techcyte
- 12.8.1 Techcyte Company Information
- 12.8.2 Techcyte Business Overview
- 12.8.3 Techcyte Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.8.4 Techcyte AI Pathology Analysis System Product Portfolio
- 12.8.5 Techcyte Recent Developments
- 12.9 Qritive
- 12.9.1 Qritive Company Information
- 12.9.2 Qritive Business Overview
- 12.9.3 Qritive Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.9.4 Qritive AI Pathology Analysis System Product Portfolio
- 12.9.5 Qritive Recent Developments
- 12.10 Deepathology
- 12.10.1 Deepathology Company Information
- 12.10.2 Deepathology Business Overview
- 12.10.3 Deepathology Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.10.4 Deepathology AI Pathology Analysis System Product Portfolio
- 12.10.5 Deepathology Recent Developments
- 12.11 Franklin.ai
- 12.11.1 Franklin.ai Company Information
- 12.11.2 Franklin.ai Business Overview
- 12.11.3 Franklin.ai Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.11.4 Franklin.ai AI Pathology Analysis System Product Portfolio
- 12.11.5 Franklin.ai Recent Developments
- 12.12 Roche Diagnostics
- 12.12.1 Roche Diagnostics Company Information
- 12.12.2 Roche Diagnostics Business Overview
- 12.12.3 Roche Diagnostics Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.12.4 Roche Diagnostics AI Pathology Analysis System Product Portfolio
- 12.12.5 Roche Diagnostics Recent Developments
- 12.13 Flagship
- 12.13.1 Flagship Company Information
- 12.13.2 Flagship Business Overview
- 12.13.3 Flagship Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.13.4 Flagship AI Pathology Analysis System Product Portfolio
- 12.13.5 Flagship Recent Developments
- 12.14 Dedalus Group
- 12.14.1 Dedalus Group Company Information
- 12.14.2 Dedalus Group Business Overview
- 12.14.3 Dedalus Group Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.14.4 Dedalus Group AI Pathology Analysis System Product Portfolio
- 12.14.5 Dedalus Group Recent Developments
- 12.15 Ibex Medical Analytics
- 12.15.1 Ibex Medical Analytics Company Information
- 12.15.2 Ibex Medical Analytics Business Overview
- 12.15.3 Ibex Medical Analytics Revenue in AI Pathology Analysis System Business (2021-2026)
- 12.15.4 Ibex Medical Analytics AI Pathology Analysis System Product Portfolio
- 12.15.5 Ibex Medical Analytics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst